Matthew Hill

Matthew Hill

Company: Elegen

Job title: Chief Executive Officer


Unlock Next-Gen mRNA Therapy Development – Rapid, Cell-Free DNA Manufacturing 9:30 am

Cell-free DNA production offers a streamlined highly scalable workflow for mRNA therapy development Elimination of cell-based cloning enables researchers to evaluate a more diverse sequence space faster Bypassing pDNA with NGS-verified, complex, full-length linear IVT-ready DNA eliminates time and costs of establishing master cell banksRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.